Boult Wade Tennant
Bulletins » EPO confirms that practice of conducting oral proceedings by videoconference will continue, including before opposition divisions.

The EPO has recently issued a decision confirming that oral proceedings before examining divisions, the Legal Division, the Receiving Section and now, permanently, opposition divisions will be held by videoconference (VICO) unless there are serious reasons for holding these in person.

This decision issues as we approach the expiry of the pilot for holding opposition division oral proceedings by VICO, which is at the end of this year. The decision enters into force on 1 January 2023 and applies to all oral proceedings before the departments of the EPO listed above that are scheduled to take place on or after that date.

At least for now, this rule does not apply to oral proceedings before the Boards of Appeal or the Enlarged Board of Appeal.

The corresponding Notice provides further updated information about the conditions and practice as regards oral proceedings by VICO. The Notice also indicates a preference to holding consultations in examination by VICO.

Some key points are set out below.

Timing

A request that oral proceedings be held in person should be filed as early as possible, preferably together with the request for oral proceedings.

A refusal of a request for oral proceedings in person will not be a separately appealable decision.

Serious reasons

The Notice provides examples of what can be considered “serious reasons” for holding such oral proceedings in person. These include:

  • reasons relating to a participant in the oral proceedings as an individual (e.g. a proven visual impairment that prevents a representative from following oral proceedings on screen); and
  • reasons related to the nature and subject-matter of the proceedings (e.g. where they involve the demonstration or inspection of an object).

However, sweeping objections based on the reliability of VICO technology or the non-availability of VICO equipment will, as a rule, not qualify as “serious reasons”.

Technical problems

Positively, the Notice confirms that where technical problems prevent the oral proceedings by VICO from being conducted or continued, a new summons will be issued. However, in line with the general rule the new oral proceedings will also be held by VICO, unless there are serious reasons for not doing so.

By contrast, if a party, witness or expert who is summoned to give evidence before the EPO fails to connect to the oral proceedings (for reasons other than technical problems), then they will be deemed not to have appeared.

Location

The Notice indicates that members of an examining division or opposition division may connect to the oral proceedings by VICO from different locations. Similarly, the parties, their representatives and any persons accompanying the parties or representatives, as well as witnesses and experts, may connect to the VICO from different locations.

Submission and transmission of documents

During oral proceedings and consultations held by VICO, documents must be filed by email. If the division consents, then a party may present its screen for illustrative purposes. However, an item displayed in this way will not be considered to constitute a document submitted by that party.

Final thoughts

Holding oral proceedings by VICO has not only helped to reduce the backlog of cases caused by the COVID-19 pandemic, but there have also been significant positive impacts on time, costs and sustainability. This is particularly the case for many of our attorneys who used to regularly travel to Munich or The Hague from the UK in order to attend oral proceedings in person.

While there may have been a few teething problems with the initial transfer to conducting most oral proceedings by VICO, this drive towards VICO is generally viewed positively for at least the reasons set out above. The resulting reduction in carbon emissions is also in line with Boult’s commitment to responsible business practices.

In general, therefore, it appears that this decision will be welcomed in the profession. The further guidance also appears reasonable and does not introduce anything unexpected.

If you have any questions, then please do not hesitate to ask me or your usual contact at Boult.

Relevant sectors
Aerospace
  • Commercial aviation
  • Defence and security
  • Space and satellites
  • Unmanned aerial vehicles
Artificial Intelligence and Machine Learning
Automotive
  • Autonomous vehicles
  • Electric vehicles
  • Engines
Biotechnology
  • Antibody engineering
  • Antibody manufacture and formulation
  • Bioinformatics
  • Biosimilars
  • Drug delivery
  • Gene editing (e.g. CRISPR)
  • Genomic and molecular tools and methods
  • GM crops
  • Immuno-oncology (e.g. checkpoint inhibitors; modified T cells)
  • Next generation sequencing
  • Nucleic acid synthesis
  • Personalised medicine/disease biomarkers
  • Recombinant protein production and purification
  • Stem cell therapies
  • Supplementary protection certificates (SPCs)
  • Synthetic biology
  • Therapeutic antibodies
  • Vaccinology (e.g. viral vectors; mRNA vaccines)
  • Women’s health products
Chemicals
  • Agrochemicals
  • Catalysts
  • Dispersions and colloids
  • Lubricants
  • Polymers and plastics
Communications and Networks
  • Cloud computing
  • Internet of things (IOT)
  • Oceanography, marine
  • Wired and wireless networks
Computing and Software
  • Artificial intelligence and machine learning
  • Bioinformatics
  • Blockchain and distributed ledgers
  • Communications and networks
  • Computer games
  • Data and software security, cryptography and digital rights management (DRM)
  • Data management and storage, databases and data compression
  • Digital assistants, virtual assistants and software agents
  • Fintech and adtech
  • Machine vision
  • Metaverse, virtual reality (VR) and augmented reality (AR)
  • Motor capture
  • Multimedia, audio/video processing and animation
  • Natural language processing
  • Quantum computing
  • Robotic process automation
  • Search engines
  • Signal processing
  • Software applications and systems, mobile applications, user interfaces
Consumer Goods and Retail
  • Anti-counterfeit devices
  • Beauty
  • Fashion
  • Health, fitness and sport
  • Household goods
  • Luxury goods
  • Moda
  • Retail
Electronics and Electrical Devices
  • Computer and IT architecture and system design
  • Medical devices
  • Optics
  • Restaurants and bars
  • Robotics
  • Scientific instruments
  • Semiconductor devices
  • Testing systems, control systems, signal processing
  • Travel and leisure
  • Wearable tech and human interfaces
Energy and Green Technologies
  • Biofuels
  • Clean air
  • Fuel cells and battery technology
  • Renewables and recycling
  • Solar power
  • Water, oil and gas, nuclear, fusion, fission
  • Wind turbines
Food and Beverage
  • Beverages
  • Nutrition
  • Retail
Industrial Manufacturing and Processing
  • Packaging
  • Polymers and plastics
  • Printing tech
  • Additive manufacturing
  • Coatings
  • Construction
Materials
  • Advanced materials
  • Composite materials
  • Metallurgy and alloys
  • Nanotechnology
Medical Devices and Diagnostics
  • Artificial intelligence
  • Devices
  • Diagnostic instruments
  • Digital health
  • Drug delivery
  • Immuno-oncology
  • In vitro diagnostics
  • Medtech
Pharmaceuticals
  • Diagnostics
  • Drug delivery
  • Generic market entry
  • Medicinal chemistry
  • Methods of production and synthesis
  • Personalised medicine/disease biomarkers
  • Pharmaceutical formulations
  • Pharmaceuticalsceutical formulations
  • Polymorphs
  • Small molecule pharmaceuticals
  • Supplementary protection certificates (SPCs)
Trade Marks
  • Consumer goods
  • Cosmetics and perfumery
  • Financial services
  • Mechanical engineering
  • Mechanical products
  • Services
  • Telecommunications